Over the past decades, electronics and biomedical engineers have developed increasingly sophisticated biosensors, devices ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...

Exposure to temperatures of 100°F (38°C) or higher may nearly triple the number of episodes of a form of irregular heart ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure monitors with AI-powered atrial fibrillation (AFib) detection feature.

Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Many of us wear devices that count our steps, measure our heart rate, track sleep patterns, and more. This information can ...

If you use a continuous glucose monitoring ... assess heart disease and fatty liver—conditions commonly linked with diabetes.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Severe temperature spikes may double or triple the risk of irregular heart rhythm in people with implanted defibrillators. An analysis of health data for more than 2,000 people with implantable ...